3692.HK
HANSOH PHARMA
HK$31.44
+0.13%
2026-05-29
About HANSOH PHARMA
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited operates as a subsidiary of Stellar Infinity Company Ltd.
Key Fundamentals
P/E Ratio
33.87
Forward P/E
28.96
EPS (TTM)
HK$1.07
ROE
17.3%
Revenue Growth (YoY)
32.0%
Profit Margin
37.0%
Debt/Equity
0.30
Dividend Yield
1.2%
Price/Book
5.41
Beta
0.55
Market Cap
HK$219.72B
Avg Volume (10D)
6.9M
Recent Breakout Signals
No recent breakout signals detected for 3692.HK.
Recent Price Range (60 Days)
60D High
HK$40.42
60D Low
HK$30.42
Avg Volume
10.2M
Latest Close
HK$31.44
Get breakout alerts for 3692.HK
Sign up for Breakout Scanner to receive daily notifications when 3692.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
HANSOH PHARMA (3692.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 3692.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 3692.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.